Targeted Genetics
Targeted Genetics officials detail recent developments
Published in Health Business Week, May 11th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Targeted Genetics.
Report 1: Targeted Genetics Corporation (NASDAQ: TGEN) today announced that Dr. Jan van Lunzen, Medical Director, University Medical Center, Hamburg Eppendorf, Germany, presented updated Phase I data from a study of tgAAC09 in healthy volunteers not infected with HIV in a poster presentation at the 14th Conference on Retroviruses and Opportunistic Infections in Los Angeles. The tgAAC09 vaccine candidate utilizes an adeno-associated virus (AAV) vector to deliver genes encoding...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2007-05-11)
More Articles from Health Business Week
- 3D Systems Corporation
3D Systems Recruits Chief Financial Officer - AARP
Calls for Rx Marketing Reform to Lower Cost of Prescription Drugs - ABB
ABB Announces PAT Solution for the Life Sciences Industry - ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals Announces Exercise of Over-Allotment by Underwriters - Aceto Corporation
Aceto Schedules Third Quarter Financial Results News Release and Conference Call - Acne Vulgaris
Acne Sufferers Trading Off Youthful Skin for Treating Acne - Two Linked Conditions - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
